//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
Retrospective study. 😊
star wars
1d
1d
Fancy stats
Aw🫰SNAP🫰 Cefazolin vs anti-staphylococcal PCN ⬇️⬇️⬇️
Caveats: - FOREST was 100% bacteremic UTI - A lower dose of oral fosfo was used (3g/48h). - Definition of relapse was more strict, requiring a new isolation of E. coli with same phenotype. - Absolute risk difference still low (11%), so definitely an option to consider if no other options! #IDSky
Sort of
🆕💥🟢Among 305 episodes with suspected infective endocarditis and valve strands the majority did not represent IE. Recurrence of IE due to the same microorganism within one year was significantly more frequent among episodes with IE compared to those without #idsky academic.oup.com/cid/article/...
Two words
If there were PK/PD issues with fosfo, the problem might arise not on early TOC, but on relapses of non-cystitis UTI. In this subanalysis of patients switched to oral in FOREST trial, more relapses were observed with fosfo for bacteremic E. coli UTI. academic.oup.com/jac/article/... #IDSky #UTIsky
1d
1d
1d
1d
1d
1d
1d
Observational indeed